| Ident. | Authors (with country if any) | Title |
|---|
| 000030 (2020) |
Fabien Huet [France] ; Cyril Prieur [France] ; Guillaume Schurtz [France] ; Edouard Gerbaud [France] ; Stéphane Manzo-Silberman [France] ; Gerald Vanzetto [France] ; Meyer Elbaz [France] ; Victoria Tea [France] ; Grégoire Mercier [France] ; Benoît Lattuca [France] ; Claire Duflos [France] ; François Roubille [France] | Acute cardiovascular diseases may be less likely to be considered because of the COVID-19 pandemic-our duty is first to alert, then to analyse more deeply: Response to a letter entitled "Severity of cardiovascular diseases during the COVID-19 pandemic" from T. Imamura. |
| 000045 (2020) |
Jean-Luc Cracowski [France] ; Mathieu Molimard [France] ; Vincent Richard [France] | Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemic. |
| 000243 (2020) |
Pedram Ahmadpoor [France, Iran] ; Lionel Rostaing [France] | Why the immune system fails to mount an adaptive immune response to a COVID-19 infection. |
| 000264 (2020) |
Hillard S. Kaplan [États-Unis] ; Benjamin C. Trumble [États-Unis] ; Jonathan Stieglitz [France] ; Roberta Mendez Mamany ; Maguin Gutierrez Cayuba ; Leonardina Maito Moye ; Sarah Alami [États-Unis] ; Thomas Kraft [France] ; Raul Quispe Gutierrez ; Juan Copajira Adrian ; Randall C. Thompson [États-Unis] ; Gregory S. Thomas [États-Unis] ; David E. Michalik [États-Unis] ; Daniel Eid Rodriguez ; Michael D. Gurven [États-Unis] | Voluntary collective isolation as a best response to COVID-19 for indigenous populations? A case study and protocol from the Bolivian Amazon. |
| 000377 (2020) |
Aurélien Mary [France] ; Lucie Hénaut [France] ; Jean-Luc Schmit [France] ; Jean-Philippe Lanoix [France] ; Michel Brazier [France] | Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy? |
| 000392 (2020) |
Dominique Bounie [France] ; Jayashree Arcot [Australie] ; Martin Cole [Australie] ; Florence Egal [Italie] ; Pablo Juliano [Australie] ; Carla Mejia [Thaïlande] ; Donna Rosa [États-Unis] ; Jay Sellahewa [Australie] | The role of food science and technology in humanitarian response. |
| 000449 (2020) |
Malgorzata Kloc [Sao Tomé-et-Principe] ; Rafik Mark Ghobrial [États-Unis] ; Jacek Z. Kubiak [Pologne, France] | The Role of Genetic Sex and Mitochondria in Response to COVID-19 Infection. |
| 000469 (2020) |
Jean-Paul Moatti [France] | The French response to COVID-19: intrinsic difficulties at the interface of science, public health, and policy. |
| 000472 (2020) |
Marc Arbyn [Belgique] ; Murat Gultekin [Turquie] ; Philippe Morice [France] ; Pekka Nieminen [Finlande] ; Maggie Cruickshank [Royaume-Uni] ; Philip Poortmans [Belgique] ; Daniel Kelly [Royaume-Uni] ; Mario Poljak [Slovénie] ; Christine Bergeron [France] ; David Ritchie [Belgique] ; Dietmar Schmidt [Allemagne] ; Maria Kyrgiou [Royaume-Uni] ; Ann Van Den Bruel [Belgique] ; Laia Bruni [Espagne] ; Partha Basu [France] ; Freddie Bray [France] ; Elisabete Weiderpass [France] | The European response to the WHO call to eliminate cervical cancer as a public health problem. |
| 000484 (2020) |
Luis Sagaon-Teyssier [France] ; Adam Yattassaye [Mali] ; Michel Bourrelly [France] ; Bintou Dembélé Keïta [Mali] ; Bruno Spire [France] | The COVID-19 response must integrate people living with HIV needs in Sub-Saharan Africa: the case of Mali. |
| 000527 (2020) |
Paul Masi ; Guillaume Hékimian ; Manon Lejeune ; Juliette Chommeloux ; Cyrielle Desnos ; Marc Pineton De Chambrun ; Isabelle Martin-Toutain ; Ania Nieszkowska ; Guillaume Lebreton ; Nicolas Bréchot ; Matthieu Schmidt ; Charles Edouard Luyt ; Alain Combes ; Corinne Frere | Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study. |
| 000594 (2020) |
Bamba Gaye [Ghana, France] ; Stéphanie Khoury [Ghana, France] ; Crystal W. Cene [Ghana, États-Unis] ; Samuel Kingue [Ghana, Cameroun] ; Roland N'Guetta [Ghana, Côte d'Ivoire] ; Camille Lassale [Espagne] ; Dadhi Baldé [Ghana, Guinée] ; Ibrahima Bara Diop [Ghana, Sénégal] ; Jennifer Beam Dowd [Royaume-Uni] ; Melinda C. Mills [Royaume-Uni] ; Xavier Jouven [Ghana, France] | Socio-demographic and epidemiological consideration of Africa's COVID-19 response: what is the possible pandemic course? |
| 000659 (2020) |
Alain R. Thierry [France] ; Benoit Roch [France] | SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure. |
| 000663 (2020) |
Marcin F. Osuchowski [Autriche] ; Federico Aletti [États-Unis] ; Jean-Marc Cavaillon [France] ; Stefanie B. Flohé [Allemagne] ; Evangelos J. Giamarellos-Bourboulis [Grèce] ; Markus Huber-Lang [Allemagne] ; Borna Relja [Allemagne] ; Tomasz Skirecki [Pologne] ; Andrea Szab [Hongrie] ; Marc Maegele [Allemagne] | SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities. |
| 000716 (2020) |
Pierre-Marie Duret [Oman] ; Lionel Spielmann [France] ; Laurent Messer [France] | Rheumatic diseases and COVID-19: a cohort of 17 patients under DMARDs. Response to: 'Comment on: Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab' by Messina et al. |
| 000732 (2020) |
Alexis Mathian [France] ; Zahir Amoura [France] | Response to: Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour et al. |
| 000733 (2020) |
Philippe Guilpain [France] ; Clément Le Bihan [France] ; Vincent Foulongne [France] ; Patrice Taourel [France] ; Nathalie Pansu [France] ; Alexandre Thibault Jacques Maria [France] ; Boris Jung [France] ; Romaric Larcher [France] ; Kada Klouche [France] ; Vincent Le Moing [France] | Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al. |
| 000734 (2020) |
Alexis Mathian [France] ; Marc Pineton De Chambrun [France] ; Alain Combes [France] ; Zahir Amoura [France] | Response to: 'Presence of anti-phospholipid antibodies in COVID-19: a case series study' by Amezcua-Guerra et al. |
| 000735 (2020) |
Alexis Mathian [France] ; Zahir Amoura [France] | Response to: 'Patients with lupus with COVID-19: University of Michigan experience' by Wallace et al. |
| 000736 (2020) |
Alexis Mathian [France] ; Zahir Amoura [France] | Response to: 'Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak' by Holubar et al. |
| 000737 (2020) |
Alexis Mathian [France] ; Zahir Amoura [France] | Response to: 'Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India' by Goyal et al. |
